Inventor · disambiguated record
Nicole S. White
Also filed as: WHITE NICOLE · WHITE NICOLE S · WHITE NICOLE SUZANNE
9 granted patents·6 pending applications·50 citations·filing 2003–2023
86Inventor score
Files withGILEAD SCIENCES INC4CELGENE CORP3NEUROCRINE BIOSCIENCES INC3ABIDE THERAPEUTICS INC1ASSEMBLY BIOSCIENCES INC1
Top patents by PatentIndex Score
15 records- 0190US8664386B2Methods for preparing anti-viral nucleotide analogsGILEAD SCIENCES INC·Filed 2012·Granted Mar 4, 2014·16 cites·7 claims
- 0289US9981930B1MAGL inhibitorsABIDE THERAPEUTICS INC·Filed 2017·Granted May 29, 2018·9 cites·20 claims
- 0389US9346841B2Methods for preparing anti-viral nucleotide analogsGILEAD SCIENCES INC·Filed 2015·Granted May 24, 2016·9 cites·4 claims
- 0488US9029534B2Methods for preparing anti-viral nucleotide analogsGILEAD SCIENCES INC·Filed 2014·Granted May 12, 2015·12 cites·6 claims
- 0586US11053199B2Crystalline (R)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piperazine-1-carboxylate, compositions and methods of use thereofCELGENE CORP·Filed 2019·Granted Jul 6, 2021·2 cites·15 claims
- 0685US11680046B2Crystalline (R)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piperazine-1-carboxylate, compositions and methods of use thereofCELGENE CORP·Filed 2021·Granted Jun 20, 2023·1 cites·12 claims
- 0777US12410133B2Crystalline (r)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piperazine-1-carboxylate, compositions and methods of use thereofCELGENE CORP·Filed 2023·Granted Sep 9, 2025·0 cites·16 claims
- 0869US11273159B2Pharmaceutical formulationsH LUNDBECK AS·Filed 2017·Granted Mar 15, 2022·1 cites·15 claims
- 0958US2024228462A1Crystalline forms of n-{3-[(1s)-1-{[6-(3,4-dimethoxyphenyl)pyrazin-2- yl]amino}ethyl]phenyl}-5-methylpyridine-3-carboxamide and related products and methodsGB002 INC·Filed 2022·Application pending·0 cites
- 1057US9676804B2Methods for preparing anti-viral nucleotide analogsGILEAD SCIENCES INC·Filed 2016·Granted Jun 13, 2017·0 cites·3 claims
- 1152US2021147367A1Crystalline forms of a magl inhibitorLUNDBECK LA JOLLA RESEARCH CENTER INC·Filed 2020·Application pending·0 cites
- 1251US2025250257A1Novel crystalline formsASSEMBLY BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1341US2005192286A1Ligands of melanocortin receptors and compositions and methods related theretoNEUROCRINE BIOSCIENCES INC·Filed 2004·Application pending·0 cites
- 1440US2004192676A1Ligands of melanocortin receptors and compositions and methods related theretoNEUROCRINE BIOSCIENCES INC·Filed 2003·Application pending·0 cites
- 1540US2004053933A1Ligands of melanocortin receptors and compositions and methods related theretoNEUROCRINE BIOSCIENCES INC·Filed 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →